{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:58:31Z","timestamp":1793361511381,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115542","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T17:19:14Z","timestamp":1695403154000},"page":"115542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The role of the serotonergic system in atropine\u2019s anti-myopic effects"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-2800","authenticated-orcid":false,"given":"Kate","family":"Thomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Karouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7938-0807","authenticated-orcid":false,"given":"Daniel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8946-9686","authenticated-orcid":false,"given":"Tamsin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115542_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: Aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog. Retin Eye Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01 % eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.biopha.2023.115542_bib4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bcp.2011.07.067","article-title":"Naturally-expressed nicotinic acetylcholine receptor subtypes","volume":"82","author":"Wu","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jop.2006.22.41","article-title":"Prevention of myopia progression with 0.05 % atropine solution","volume":"22","author":"Lee","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5 %, 0.1 %, and 0.01 % doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.biopha.2023.115542_bib7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/jop.1997.13.61","article-title":"The effectiveness of 0.5 % atropine in controlling high myopia in children","volume":"13","author":"Chou","year":"1997","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10384-006-0380-7","article-title":"Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study","volume":"51","author":"Fan","year":"2007","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih","year":"1999","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-0420.2001.790304.x","article-title":"An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression","volume":"79","author":"Shih","year":"2001","journal-title":"Acta Ophthalmol. Scand."},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2023.115542_bib12","first-page":"281","article-title":"Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students","volume":"15","author":"Kennedy","year":"2000","journal-title":"Binocul. Vis. Strabismus Q"},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05 %, 0.025 %, and 0.01 % atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib14","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI\u2013interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib15","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.18-25967","article-title":"IMI - report on experimental models of emmetropization and myopia","volume":"60","author":"Troilo","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/opo.12052","article-title":"How does atropine exert its anti\u2010myopia effects?","volume":"33","author":"McBrien","year":"2013","journal-title":"Ophthalmic Physiol. Opt."},{"issue":"22","key":"10.1016\/j.biopha.2023.115542_bib17","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1111\/bph.15629","article-title":"Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release","volume":"178","author":"Thomson","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1124\/mol.52.5.886","article-title":"Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects","volume":"52","author":"Zwart","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bjp.0705124","article-title":"Interactions of atropine with heterologously expressed and native \u03b13 subunit\u2010containing nicotinic acetylcholine receptors","volume":"138","author":"Parker","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115542_bib20","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1167\/iovs.17-22562","article-title":"Myopia-inhibiting concentrations of muscarinic receptor antagonists block activation of alpha2A-adrenoceptors in vitro","volume":"59","author":"Carr","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2023.115542_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2016.04.027","article-title":"The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors","volume":"108","author":"Lochner","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2023.115542_bib22","first-page":"1","article-title":"Functional anatomy of the neural retina","volume":"2","author":"Marc","year":"2008","journal-title":"Albert Jakobiec\u2019s Princ. Pract. Ophthalmol."},{"key":"10.1016\/j.biopha.2023.115542_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.11.006","article-title":"Serotonin in retina","volume":"161","author":"Masson","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06270.x","article-title":"Serotonin released from amacrine neurons is scavenged and degraded in bipolar neurons in the retina","volume":"111","author":"Ghai","year":"2009","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.biopha.2023.115542_bib25","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100350RR","article-title":"Transcriptome-based insights into gene networks controlling myopia prevention","volume":"35","author":"Karouta","year":"2021","journal-title":"Faseb J."},{"issue":"12","key":"10.1016\/j.biopha.2023.115542_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167902","article-title":"Effects of constant flickering light on refractive status, 5-HT and 5-HT2A receptor in guinea pigs","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.exer.2005.03.021","article-title":"Retinal serotonin, eye growth and myopia development in chick","volume":"81","author":"George","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1017\/S0952523800012153","article-title":"Concentrations of biogenic amines in fundal layers in chickens with normal visual experience, deprivation, and after reserpine application","volume":"14","author":"Ohngemach","year":"1997","journal-title":"Vis. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1167\/iovs.14-15499","article-title":"Correlation between light levels and the development of deprivation myopia","volume":"56","author":"Karouta","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70271-z","article-title":"Levodopa inhibits the development of lens-induced myopia in chicks","volume":"10","author":"Thomson","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1476-5381.1990.tb14113.x","article-title":"Characterization of 5\u2013HT3 and \u2018atypical\u20195\u2013HT receptors mediating guinea\u2010pig ileal contractions in vitro","volume":"101","author":"Eglen","year":"1990","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.biopha.2023.115542_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0024-3205(93)90171-X","article-title":"Receptors implicated in the actions of serotonin on chicken ileum longitudinal smooth muscle","volume":"52","author":"Martin","year":"1993","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(90)90513-6","article-title":"1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist","volume":"182","author":"Kilpatrick","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54789-5","article-title":"Effectiveness and safety of topical levodopa in a chick model of myopia","volume":"9","author":"Thomson","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2023.115542_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.61.12.4","article-title":"Form-deprivation and lens-induced myopia are similarly affected by pharmacological manipulation of the dopaminergic system in chicks","volume":"61","author":"Thomson","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.exer.2006.09.018","article-title":"Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia","volume":"84","author":"McCarthy","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115542_bib37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.1971.tb12034.x","article-title":"Studies in vivo on the relationship between brain tryptophan, brain 5\u2013HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L\u2010tryptophan","volume":"18","author":"Grahame\u2010Smith","year":"1971","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archgenpsychiatry.2007.11","article-title":"Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy","volume":"65","author":"Barton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/000456329403100302","article-title":"The measurement of 5-hydroxyindoleacetic acid in urine","volume":"31","author":"Deacon","year":"1994","journal-title":"Ann. Clin. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0004563215613109","article-title":"Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement","volume":"53","author":"Adaway","year":"2016","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/biology10020076","article-title":"The role of serum 5-HIAA as a predictor of progression and an alternative to 24-h urine 5-HIAA in well-differentiated neuroendocrine neoplasms","volume":"10","author":"Wedin","year":"2021","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0361-9230(92)90252-S","article-title":"In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats","volume":"28","author":"Shimizu","year":"1992","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0742-8413(85)90077-5","article-title":"The influence of testosterone in the brain of the male rat on levels of serotonin (5-HT) and hydroxyindole-acetic acid (5-HIAA)","volume":"80","author":"Martinez-Conde","year":"1985","journal-title":"Comp. Biochem. Physiol. Part C: Comp. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115542_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-003-1736-z","article-title":"Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release","volume":"172","author":"Stenfors","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000227636","article-title":"Serotonin mechanisms in","volume":"53","author":"Cubeddu","year":"1996","journal-title":"Oncology"},{"issue":"19","key":"10.1016\/j.biopha.2023.115542_bib46","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/0024-3205(88)90023-9","article-title":"Changes in plasma and brain tryptophan and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress","volume":"42","author":"Dunn","year":"1988","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib47","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1471-4159.1988.tb01107.x","article-title":"Endogenous release of neuronal serotonin and 5\u2013hydroxyindoleacetic acid in the caudate\u2010putamen of the rat as revealed by intracerebral dialysis coupled to high\u2010performance liquid chromatography with fluorimetric detection","volume":"51","author":"Kal\u00e9n","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2023.115542_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.02.007","article-title":"An updated view on the role of dopamine in myopia","volume":"114","author":"Feldkaemper","year":"2013","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.4.25","article-title":"Coadministration with carbidopa enhances the antimyopic effects of levodopa in chickens","volume":"62","author":"Thomson","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115542_bib50","first-page":"1368","article-title":"The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew","volume":"37","author":"Cottriall","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib51","first-page":"205","article-title":"Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism","volume":"34","author":"McBrien","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.115542_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1076\/ceyr.16.10.992.9021","article-title":"The effect of nitric oxide synthase inhibitor on form-deprivation myopia","volume":"16","author":"Fujikado","year":"1997","journal-title":"Curr. Eye Res."},{"issue":"307","key":"10.1016\/j.biopha.2023.115542_bib53","first-page":"2824","article-title":"Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs","volume":"17","author":"Dong","year":"2011","journal-title":"Mol. Vis."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib54","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1167\/iovs.13-12361","article-title":"Daily injection but not continuous infusion of apomorphine inhibits form-deprivation myopia in mice","volume":"56","author":"Yan","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2023.115542_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108233","article-title":"Topical application of dopaminergic compounds can inhibit deprivation myopia in chicks","volume":"200","author":"Thomson","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib56","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002100100460","article-title":"Diisopropylfluorophosphate alters retinal neurotransmitter levels and reduces experimentally-induced myopia","volume":"364","author":"Cottriall","year":"2001","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0014-4835(05)80147-2","article-title":"Dose-dependent effects of intravitreal pirenzepine on deprivation myopia and lens-induced refractive errors in chickens","volume":"61","author":"Rickers","year":"1995","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115542_bib58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00734814","article-title":"Rhythmic regulation of retinal melatonin: metabolic pathways, neurochemical mechanisms, and the ocular circadian clock","volume":"11","author":"Cahill","year":"1991","journal-title":"Cell Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115542_bib59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0042-6989(94)00221-7","article-title":"Studies on the role of the retinal dopamine\/melatonin system in experimental refractive errors in chickens","volume":"35","author":"Schaeffel","year":"1995","journal-title":"Vis. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.05-0195","article-title":"Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation","volume":"47","author":"Rada","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0197-0186(95)00050-I","article-title":"Melatonin and deprivation myopia in chickens","volume":"28","author":"Hoffmann","year":"1996","journal-title":"Neurochem. Int."},{"issue":"18","key":"10.1016\/j.biopha.2023.115542_bib62","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1074\/jbc.M114.559542","article-title":"Convergence of melatonin and serotonin (5-HT) signaling at MT2\/5-HT2C receptor heteromers","volume":"290","author":"Kamal","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-016-0002-7","article-title":"Nitric oxide (NO) mediates the inhibition of form-deprivation myopia by atropine in chicks","volume":"6","author":"Carr","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2023.115542_bib64","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1021\/pr500558y","article-title":"Involvement of GABA transporters in atropine-treated myopic retina as revealed by iTRAQ quantitative proteomics","volume":"13","author":"Barathi","year":"2014","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0952523800171184","article-title":"Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick","volume":"17","author":"Schwahn","year":"2000","journal-title":"Vis. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00417-019-04573-y","article-title":"Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken","volume":"258","author":"Mathis","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115542_bib67","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.exer.2009.01.012","article-title":"Inhibiting the neuronal isoform of nitric oxide synthase has similar effects on the compensatory choroidal and axial responses to myopic defocus in chicks as does the non-specific inhibitor L-NAME","volume":"88","author":"Nickla","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib68","first-page":"111","article-title":"The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens","volume":"81","author":"Nickla","year":"2004","journal-title":"Optom. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000055647","article-title":"Effect of a nitric oxide synthase inhibitor on lens-induced myopia","volume":"33","author":"Fujikado","year":"2001","journal-title":"Ophthalmic Res."},{"issue":"11","key":"10.1016\/j.biopha.2023.115542_bib70","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/OPX.0000000000000041","article-title":"Nitric oxide synthase inhibitors prevent the growth-inhibiting effects of quinpirole","volume":"90","author":"Nickla","year":"2013","journal-title":"Optom. Vis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115542_bib71","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.89.6.2365","article-title":"ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ","volume":"89","author":"Haycock","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00966919","article-title":"Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40","volume":"18","author":"Haycock","year":"1993","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib73","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1986.tb12980.x","article-title":"Phorbol 12,13-dibutyrate increases tyrosine hydroxylase activity in the superior cervical ganglion of the rat","volume":"46","author":"Wang","year":"1986","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115542_bib74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0169-328X(96)00030-7","article-title":"Regulation of tyrosine hydroxylase gene expression by the m1 muscarinic acetylcholine receptor in rat pheochromocytoma cells","volume":"40","author":"Chen","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115542_bib75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3565(25)30803-7","article-title":"Tyrosine hydroxylase: delayed activation in central noradrenergic neurons and induction in adrenal medulla elicited by stimulation of central cholinergic receptors","volume":"200","author":"Lewander","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib76","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1159\/000515755","article-title":"Effects of single and repeated intravitreal applications of atropine on choroidal thickness in alert chickens","volume":"64","author":"Mathis","year":"2021","journal-title":"Ophthalmic Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib77","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-8993(99)01599-1","article-title":"Nitric oxide modulates the release of serotonin in the rat hypothalamus","volume":"835","author":"Kaehler","year":"1999","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115542_bib78","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin-dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2023.115542_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/MN:26:2-3:203","article-title":"Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications","volume":"26","author":"Yan","year":"2002","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2023.115542_bib80","first-page":"1277","article-title":"Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation","volume":"15","author":"Barathi","year":"2009","journal-title":"Mol. Vis."},{"issue":"8","key":"10.1016\/j.biopha.2023.115542_bib81","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1167\/iovs.06-1538","article-title":"Form-deprivation myopia in chick induces limited changes in retinal gene expression","volume":"48","author":"McGlinn","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2023.115542_bib82","first-page":"2608","article-title":"Effects of intravitreal insulin and insulin signaling cascade inhibitors on emmetropization in the chick","volume":"18","author":"Penha","year":"2012","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115542_bib83","doi-asserted-by":"crossref","first-page":"L282","DOI":"10.1152\/ajplung.1999.277.2.L282","article-title":"Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion","volume":"277","author":"Lee","year":"1999","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:19:53Z","timestamp":1776460793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":83,"alternative-id":["S0753332223013409"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115542","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the serotonergic system in atropine\u2019s anti-myopic effects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115542"}}